ALDX
Aldeyra Therapeutics, Inc.
Overview
Aldeyra Therapeutics, Inc is a Healthcare company operating in Biotechnology with a $123.7M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
8 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q4 FY2022Earnings2023-03-0917 Q&A exchanges
- Q3 FY2022Earnings2022-11-1016 Q&A exchanges
- Q2 FY2022Earnings2022-08-0520 Q&A exchanges
- Q1 FY2022Earnings2022-05-0520 Q&A exchanges
- Q4 FY2021Earnings2022-03-1716 Q&A exchanges
- Q3 FY2021Earnings2021-10-2827 Q&A exchanges
- Q2 FY2021Earnings2021-08-0514 Q&A exchanges
- Q1 FY2021Earnings2021-05-0620 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-05EPS— vs $-0.11—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | $-0.11 | — | — | — | — | EODHD |
Source: EODHD. ALDX reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks ALDX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2022 | $2.75 | $3.02 | -9.1% | +5.2% | +5.4% |
| Q4 FY2022 | $2.72 | $3.20 | -15.0% | +0.7% | +0.5% |
| Q3 FY2022 | $2.44 | $3.09 | -21.1% | -2.2% | -0.8% |
| Q2 FY2022 | $2.74 | $3.02 | -9.2% | -1.1% | -2.4% |
| Q1 FY2021 | $2.37 | $3.01 | -21.3% | -2.0% | -4.4% |
| Q4 FY2021 | $2.57 | $3.07 | -16.4% | +3.8% | +5.0% |
| Q3 FY2021 | $2.72 | $3.13 | -13.0% | +2.9% | +2.9% |
| Q2 FY2021 | $2.44 | $3.12 | -21.9% | -3.8% | -4.1% |
| Q1 FY2020 | $2.60 | $3.16 | -17.7% | +0.1% | +0.6% |
| Q4 FY2020 | $2.69 | $3.31 | -18.7% | +0.8% | -2.1% |
Guidance change history
Sample- Q1 FY2022Lowered2022-04-15
- Q4 FY2022Lowered2022-13-15
- Q3 FY2022Lowered2022-10-15
- Q2 FY2022Lowered2022-07-15
- Q1 FY2021Lowered2021-04-15
- Q4 FY2021Lowered2021-13-15
- Q3 FY2021Lowered2021-10-15
- Q2 FY2021Lowered2021-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Todd C BradyCEO2 yr 9 mo7 callsCurrentSample
CEO since 2023 • 2/2 beats (100%) • guidance suspended Q1 FY2022
- Stephen MacHathaChief Development Officer2 yr 3 mono recorded callsCurrentSample
OTHER_C_SUITE since 2024 • 1/2 beats (50%) • last guidance raise Q2 FY2022
- Michael AlfieriPrincipal Financial Officer1 yr 10 mono recorded callsCurrentSample
OTHER since 2024 • 1/2 beats (50%) • last guidance cut Q2 FY2022
- Bruce GreenbergSee Remarks5 mo3 callsFormerSample
OTHER since 2024 • 1/2 beats (50%) • guidance suspended Q2 FY2022
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ALDX.
$ curl https://api.spokenalpha.com/v1/companies/ALDXFAQ
Frequently asked about ALDX
Where can I find Aldeyra Therapeutics, Inc.'s (ALDX) earnings call transcripts?
Spoken Alpha indexes ALDX's earnings call transcripts at https://spokenalpha.com/companies/ALDX. Each call links to attributed speakers and parsed analyst Q&A. Aldeyra Therapeutics, Inc.'s own investor relations page is at https://ir.aldeyra.com/investor-relations.
When was Aldeyra Therapeutics, Inc.'s most recent earnings call?
Aldeyra Therapeutics, Inc. (ALDX) held its most recent earnings call on 2023-03-09, covering fiscal Q4 2022.
What sector is ALDX in?
Aldeyra Therapeutics, Inc. (ALDX) operates in the Healthcare sector (Biotechnology industry).